Skip to main content
Erschienen in:

05.12.2023 | Original Article

Effect of Iron Polymaltose Complex Prophylaxis on Frequency of Iron Deficiency and Iron Deficiency Anemia

verfasst von: Dilek Konuksever, Namık Yaşar Özbek

Erschienen in: Indian Journal of Pediatrics | Ausgabe 2/2025

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the effectiveness of national iron prophylaxis policy in 9–12 mo-old infants in Turkey.

Methods

This study was planned as a cross-sectional study, and it included healthy infants aged 9 to 12 mo who presented to the pediatric outpatient clinic for routine check-ups. Parents were interviewed to identify risk factors for iron deficiency (ID) and gather information on Fe+3 - iron polymaltose complex (IPC) prophylaxis usage. Blood samples were collected for hemogram and ferritin analysis. Multiple logistic regression analyses were conducted to determine risk factors for ID and iron deficiency anemia (IDA).

Results

The study included 317 infants. In the non-prophylaxis group, the frequency of IDA was 31.1%, compared to 13.4% in the regular prophylaxis group. Iron deficiency was detected in 25% of individuals receiving regular prophylaxis and 13.1% of those without prophylaxis. The risk factors for IDA were insufficient iron diets (OR 2.45, 95% CI: 1.35–4.45) and not receiving Fe+3 - IPC prophylaxis (OR 2.57, 95% CI: 1.24–5.31). The relationship between Fe+3 - IPC prophylaxis and ID did not reach statistical significance (p = 0.253).

Conclusions

Fe+3 - IPC prophylaxis is associated with a lower risk of iron deficiency anemia, but not iron deficiency.
Literatur
2.
Zurück zum Zitat Wessling-Resnick M. Iron: Basic nutritional aspects. In: Collins JF, editor. Molecular. Genetic, and Nutritional Aspects of Major and Trace Minerals: Boston, MA; Academic Press; 2017. p. 161–73. Wessling-Resnick M. Iron: Basic nutritional aspects. In: Collins JF, editor. Molecular. Genetic, and Nutritional Aspects of Major and Trace Minerals: Boston, MA; Academic Press; 2017. p. 161–73.
3.
Zurück zum Zitat Rosli RRM, Norhayati MN, Ismail SB. Effectiveness of iron polymaltose complex in treatment and prevention of iron deficiency anemia in children: A systematic review and meta-analysis. Peer J. 2021;9:e10527.CrossRef Rosli RRM, Norhayati MN, Ismail SB. Effectiveness of iron polymaltose complex in treatment and prevention of iron deficiency anemia in children: A systematic review and meta-analysis. Peer J. 2021;9:e10527.CrossRef
5.
Zurück zum Zitat Ferri C, Procianoy RS, Silveira RC. Prevalence and risk factors for iron-deficiency anemia in very-low-birth-weight preterm infants at 1 year of corrected age. J Trop Pediatr. 2014;60:53–60.CrossRefPubMed Ferri C, Procianoy RS, Silveira RC. Prevalence and risk factors for iron-deficiency anemia in very-low-birth-weight preterm infants at 1 year of corrected age. J Trop Pediatr. 2014;60:53–60.CrossRefPubMed
6.
Zurück zum Zitat Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 2010;126:1040–50.CrossRefPubMed Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 2010;126:1040–50.CrossRefPubMed
7.
Zurück zum Zitat Yalçın SS, Tezel B, Yurdakök K, et al. A community-based iron supplementation program, “Iron-Like Turkey”, and the following prevalence of anemia among infants aged 12–23 months. Turk J Pediatr. 2013;55:16–28.PubMed Yalçın SS, Tezel B, Yurdakök K, et al. A community-based iron supplementation program, “Iron-Like Turkey”, and the following prevalence of anemia among infants aged 12–23 months. Turk J Pediatr. 2013;55:16–28.PubMed
8.
Zurück zum Zitat Pasricha S-R, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397:233–48.CrossRefPubMed Pasricha S-R, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397:233–48.CrossRefPubMed
9.
Zurück zum Zitat Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA. 1999;281:2225–30.CrossRefPubMed Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA. 1999;281:2225–30.CrossRefPubMed
10.
Zurück zum Zitat Lanzkowsky P. Iron-deficiency anemia. In: Lanzkowsky P, Lipton JM, Fish JD, editors. Lanzkowsky’s Manual of Pediatric Hematology and Oncology. 6th ed. London: Elsevier; 2016. p. 69–83.CrossRef Lanzkowsky P. Iron-deficiency anemia. In: Lanzkowsky P, Lipton JM, Fish JD, editors. Lanzkowsky’s Manual of Pediatric Hematology and Oncology. 6th ed. London: Elsevier; 2016. p. 69–83.CrossRef
11.
Zurück zum Zitat Zikidou P, Tsigalou C, Trypsianis G, Karvelas A, Tsalkidis A, Mantadakis E. Prevalence of anemia, iron deficiency, and iron deficiency anemia and diagnostic performance of hematologic and biochemical markers of sideropenia in 1-to 5-year-old children in Thrace Greece. Mediterr J Hematol Infect Dis. 2022;14:e2022054.CrossRefPubMedPubMedCentral Zikidou P, Tsigalou C, Trypsianis G, Karvelas A, Tsalkidis A, Mantadakis E. Prevalence of anemia, iron deficiency, and iron deficiency anemia and diagnostic performance of hematologic and biochemical markers of sideropenia in 1-to 5-year-old children in Thrace Greece. Mediterr J Hematol Infect Dis. 2022;14:e2022054.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Friel J, Qasem W, Cai C. Iron and the breastfed infant Antioxidants. 2018;7:54.PubMed Friel J, Qasem W, Cai C. Iron and the breastfed infant Antioxidants. 2018;7:54.PubMed
13.
Zurück zum Zitat Jaber L, Rigler S, Taya A, et al. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy. J Pediatr Hematol Oncol. 2010;32:585–8.CrossRefPubMed Jaber L, Rigler S, Taya A, et al. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy. J Pediatr Hematol Oncol. 2010;32:585–8.CrossRefPubMed
14.
Zurück zum Zitat Aycicek A, Koc A, Oymak Y, Selek S, Kaya C, Guzel B. Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia. J Pediatr Hematol Oncol. 2014;36:57–61.CrossRefPubMed Aycicek A, Koc A, Oymak Y, Selek S, Kaya C, Guzel B. Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia. J Pediatr Hematol Oncol. 2014;36:57–61.CrossRefPubMed
15.
Zurück zum Zitat Arvas A, Gür E. Are ferric compounds useful in treatment of iron deficiency anemia? Turk J Pediatr. 2000;42:352–3.PubMed Arvas A, Gür E. Are ferric compounds useful in treatment of iron deficiency anemia? Turk J Pediatr. 2000;42:352–3.PubMed
16.
Zurück zum Zitat Liu T-C, Lin S-F, Chang C-S, Yang W-C, Chen T-P. Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of iron deficiency anemia: A Taiwanese study. Int J Hematol. 2004;80:416–20.CrossRefPubMed Liu T-C, Lin S-F, Chang C-S, Yang W-C, Chen T-P. Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of iron deficiency anemia: A Taiwanese study. Int J Hematol. 2004;80:416–20.CrossRefPubMed
17.
Zurück zum Zitat Bopche AV, Dwivedi R, Mishra R, Patel G. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children. Indian Pediatr. 2009;46:883–5.PubMed Bopche AV, Dwivedi R, Mishra R, Patel G. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children. Indian Pediatr. 2009;46:883–5.PubMed
18.
Zurück zum Zitat Ozsoylu S, Ozbek N. Bioavailability of iron. Exp Hematol. 1991;19:1065.PubMed Ozsoylu S, Ozbek N. Bioavailability of iron. Exp Hematol. 1991;19:1065.PubMed
19.
Zurück zum Zitat Johnson G, Jacobs P. Bioavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals. Exp Hematol. 1990;18:1064–9.PubMed Johnson G, Jacobs P. Bioavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals. Exp Hematol. 1990;18:1064–9.PubMed
20.
21.
Zurück zum Zitat Nielsen P, Gabbe E, Fischer R, Heinrich H. Bioavailability of iron from oral ferric polymaltose in humans. Arzneimittelforschung. 1994;44:743–8.PubMed Nielsen P, Gabbe E, Fischer R, Heinrich H. Bioavailability of iron from oral ferric polymaltose in humans. Arzneimittelforschung. 1994;44:743–8.PubMed
22.
Zurück zum Zitat Ruiz-Argüelles GJ, Díaz-Hernández A, Manzano C, Ruiz-Delgado GJ. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia. Hematology. 2007;12:255–6.CrossRefPubMed Ruiz-Argüelles GJ, Díaz-Hernández A, Manzano C, Ruiz-Delgado GJ. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia. Hematology. 2007;12:255–6.CrossRefPubMed
23.
Zurück zum Zitat Patil P, Geevarghese P, Khaire P, et al. Comparison of therapeutic efficacy of ferrous ascorbate and iron polymaltose complex in iron deficiency anemia in children: A randomized controlled trial. Indian J Pediatr. 2019;86:1112–7.CrossRefPubMed Patil P, Geevarghese P, Khaire P, et al. Comparison of therapeutic efficacy of ferrous ascorbate and iron polymaltose complex in iron deficiency anemia in children: A randomized controlled trial. Indian J Pediatr. 2019;86:1112–7.CrossRefPubMed
24.
Zurück zum Zitat Bakht S, Ikram M, Shirazi SS, Saif OB, Rehman FU, Saif A. Comparison of efficacy and tolerability of iron polymaltose complex with ferrous sulphate in treatment of children with iron deficiency anemia. Rawal Med J. 2022;47:606–9. Bakht S, Ikram M, Shirazi SS, Saif OB, Rehman FU, Saif A. Comparison of efficacy and tolerability of iron polymaltose complex with ferrous sulphate in treatment of children with iron deficiency anemia. Rawal Med J. 2022;47:606–9.
25.
Zurück zum Zitat Zaman S, Khan MM, Tabussam S, Nawaz S, Ayub A, Shah SA. Comparison of ferrous sulphate versus iron polymaltose complex in the treatment of iron deficiency anemia in children. Pak J Med Health Sci. 2022;16:308.CrossRef Zaman S, Khan MM, Tabussam S, Nawaz S, Ayub A, Shah SA. Comparison of ferrous sulphate versus iron polymaltose complex in the treatment of iron deficiency anemia in children. Pak J Med Health Sci. 2022;16:308.CrossRef
26.
Zurück zum Zitat Powers JM, Buchanan GR, Adix L, Zhang S, Gao A, McCavit TL. Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: A randomized clinical trial. JAMA. 2017;317:2297–304.CrossRefPubMedPubMedCentral Powers JM, Buchanan GR, Adix L, Zhang S, Gao A, McCavit TL. Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: A randomized clinical trial. JAMA. 2017;317:2297–304.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Yasa B, Agaoglu L, Unuvar E. Efficacy, tolerability, and acceptability of iron hydroxide polymaltose complex versus ferrous sulfate: A randomized trial in pediatric patients with iron deficiency anemia. Int J Pediatr. 2011;2011:524520.CrossRefPubMedPubMedCentral Yasa B, Agaoglu L, Unuvar E. Efficacy, tolerability, and acceptability of iron hydroxide polymaltose complex versus ferrous sulfate: A randomized trial in pediatric patients with iron deficiency anemia. Int J Pediatr. 2011;2011:524520.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Raffaeli G, Manzoni F, Cortesi V, Cavallaro G, Mosca F, Ghirardello S. Iron homeostasis disruption and oxidative stress in preterm newborns. Nutrients. 2020;12:1554.CrossRefPubMedPubMedCentral Raffaeli G, Manzoni F, Cortesi V, Cavallaro G, Mosca F, Ghirardello S. Iron homeostasis disruption and oxidative stress in preterm newborns. Nutrients. 2020;12:1554.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Andersen ATN, Husby S, et al. Iron deficiency in healthy 18-month-old Danish children is associated with no oral iron supplementation in infancy and prolonged exclusive breast-feeding. Br J Nutr. 2019;122:1409–16.CrossRefPubMed Andersen ATN, Husby S, et al. Iron deficiency in healthy 18-month-old Danish children is associated with no oral iron supplementation in infancy and prolonged exclusive breast-feeding. Br J Nutr. 2019;122:1409–16.CrossRefPubMed
Metadaten
Titel
Effect of Iron Polymaltose Complex Prophylaxis on Frequency of Iron Deficiency and Iron Deficiency Anemia
verfasst von
Dilek Konuksever
Namık Yaşar Özbek
Publikationsdatum
05.12.2023
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 2/2025
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-023-04930-0

Kompaktes Leitlinien-Wissen Pädiatrie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Pädiatrie

Wie gefährlich sind E-Zigaretten?

E-Zigaretten (Vaper) sind nicht harmlos – sie verführen zur parallelen Nutzung von E- und Tabakzigaretten (Dual Use) und machen das Rauchen für junge Menschen attraktiv u.a. aufgrund der vielfältigen Aromastoffe. Ein niedrigschwelliger Einstieg in die Tabakentwöhnung könnten digitale Anwendungen (DiGA) sein. 

ePA für Kinder und Jugendliche: Neue KBV-Richtlinie schafft Klarheit für Arztpraxen

Mit einer neuen Richtlinie will die Kassenärztliche Bundesvereinigung in Abstimmung mit dem Bundesministerium für Gesundheit Sorgen der Kolleginnen und Kollegen beim Umgang mit der Kinder-ePA ausräumen. Die Richtlinie gerät arg kurz – Pädiater und Pädiaterinnen reagieren dennoch zufrieden.

Weniger Bargeld, weniger Erstickungsnotfälle?

Dadurch, dass immer seltener mit Bargeld gezahlt wird, könnte die Rate an Erstickungsnotfällen bei Kindern zurückgehen. Dieser Hypothese ist ein britisches Forschungsteam in Klinikdaten aus den letzten zweieinhalb Jahrzehnten nachgegangen.

Pneumonie ausschließen: Auf das Röntgenbild ist offenbar Verlass

Das Thoraxröntgen ist gemäß Daten aus den USA eine zuverlässige Methode, um bei Kindern in der Notaufnahme rasch eine Lungenentzündung auszuschließen. Zur Vorsicht rät das Ärzteteam jedoch bei bestimmten klinischen Symptomen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.